World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
120
Citations
82968
World Ranking
3665
National Ranking
142

Harry J.G.M. Crijns publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Harry J.G.M. Crijns sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 645 publications — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Harry J.G.M. Crijns D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Harry J.G.M. Crijns sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 120 D-Index — 82nd percentile

82% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Harry J.G.M. Crijns is affiliated with Maastricht University Medical Centre in the Netherlands. Their research primarily focuses on medicine, with a specialization in cardiology and cardiovascular medicine.

The scientist's work spans several subfields including cardiology and cardiovascular medicine, surgery, radiology, nuclear medicine and imaging, molecular biology, and pulmonary and respiratory medicine.

Main topics of research include:

  • Atrial Fibrillation Management and Outcomes
  • Cardiac Arrhythmias and Treatments
  • Cardiac electrophysiology and arrhythmias
  • Cardiac pacing and defibrillation studies
  • Cardiovascular Function and Risk Factors
  • Cardiac Imaging and Diagnostics
  • Cardiovascular Syncope and Autonomic Disorders

Crijns has published extensively in key cardiovascular journals. Frequent publication venues include:

  • EP Europace (41 publications)
  • European Heart Journal (25 publications)
  • Netherlands Heart Journal (10 publications)
  • Circulation (9 publications)
  • IJC Heart & Vasculature (9 publications)

Frequent co-authors in their research network are:

  • Ulrich Schotten (63 collaborations)
  • Isabelle C. Van Gelder (51 collaborations)
  • Dominik Linz (50 collaborations)
  • Michiel Rienstra (44 collaborations)
  • Paulus Kirchhof (36 collaborations)

Recent significant papers include:

  • 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS), 2020, published in European Heart Journal
  • Early Rhythm-Control Therapy in Patients with Atrial Fibrillation, 2020, New England Journal of Medicine
  • 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS), 2024, European Heart Journal
  • Catheter Ablation in End-Stage Heart Failure with Atrial Fibrillation, 2023, New England Journal of Medicine
  • How to use digital devices to detect and manage arrhythmias: an EHRA practical guide, 2022, EP Europace

Best Publications

  • Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.

    Gregory Y. H. Lip;Robby Nieuwlaat;Ron Pisters;Deirdre A. Lane

  • 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design

    Hugh Calkins;Karl Heinz Kuck;Riccardo Cappato;Josep Brugada

  • A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey.

    Ron Pisters;Deirdre A. Lane;Robby Nieuwlaat;Cees B. de Vos

  • 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: Recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design

    Hugh Calkins;Karl Heinz Kuck;Riccardo Cappato;Josep Brugada

  • HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: Recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation

    Hugh Calkins;Josep Brugada;Douglas L. Packer;Ricardo Cappato

  • Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies

    Yanti Octavia;Carlo G. Tocchetti;Kathleen L. Gabrielson;Stefan Janssens

  • Effect of dronedarone on cardiovascular events in atrial fibrillation.

    Stefan H. Hohnloser;Martin van Eickels;Christophe Gaudin;Richard L. Page

  • 2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Updating the 2006 Guideline) A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

    L. Samuel Wann;Anne B. Curtis;Kenneth A. Ellenbogen;N.A. Mark Estes

  • Atrial fibrillation management: a prospective survey in ESC Member Countries The Euro Heart Survey on Atrial Fibrillation

    Robby Nieuwlaat;Alessandro Capucci;A John Camm;S Bertil Olsson

  • Increased Mortality after Dronedarone Therapy for Severe Heart Failure

    Lars Køber;Christian Torp-Pedersen;John J.V. McMurray;Ole Gøtzsche

  • 2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

    Valentin Fuster;Lars E. Rydén;Davis S. Cannom;Harry J. Crijns

  • Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction.

    Umesh C. Sharma;Saraswati Pokharel;Thomas J. van Brakel;Jop H. van Berlo

  • ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation–executive summary. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation)

    Valentin Fuster;Lars E. Rydén;David S. Cannom;Harry J. Crijns

  • 2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society

    Valentin Fuster;Lars E. Rydén;Davis S. Cannom;Harry J. Crijns

  • Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter

    Bramah N. Singh;Stuart J. Connolly;Denis Roy;Peter R. Kowey

  • Progression From Paroxysmal to Persistent Atrial Fibrillation: Clinical Correlates and Prognosis

    Cees B. de Vos;Ron Pisters;Robby Nieuwlaat;Martin H. Prins

  • Multi-Ethnic Genome-wide Association Study for Atrial Fibrillation

    Carolina Roselli;Mark D. Chaffin;Lu Chen Weng;Lu Chen Weng;Stefanie Aeschbacher

  • Utility of Amino-Terminal Pro-Brain Natriuretic Peptide, Galectin-3, and Apelin for the Evaluation of Patients With Acute Heart Failure

    Roland R. van Kimmenade;James L. Januzzi;Patrick T. Ellinor;Umesh C. Sharma

  • Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) Study.

    Vincent E. Hagens;Adelita V. Ranchor;Eric Van Sonderen;Hans A. Bosker

  • ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation - executive summary: A report of the American College of Cardiology/American Heart Aassociation task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to revise the 2001 guidelines for the management of patients With atrial fibrillation)Guidelines for the Management of Patients With Atrial Fibrillation)

    Jeffrey L. Anderson;Cynthia D. Adams;Elliott M. Antman;Charles R. Bridges

Frequent Co-Authors

Isabelle C. Van Gelder
Isabelle C. Van Gelder University Medical Center Groningen
Gregory Y.H. Lip
Gregory Y.H. Lip University of Liverpool
Paulus Kirchhof
Paulus Kirchhof University of Birmingham
A. John Camm
A. John Camm St George's, University of London
Frits W. Prinzen
Frits W. Prinzen Maastricht University
Giuseppe Boriani
Giuseppe Boriani University of Modena and Reggio Emilia
Martin H. Prins
Martin H. Prins Maastricht University
Deirdre A. Lane
Deirdre A. Lane University of Liverpool
Dirk J. van Veldhuisen
Dirk J. van Veldhuisen University Medical Center Groningen
Jan G.P. Tijssen
Jan G.P. Tijssen University of Amsterdam

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Medicine is a diverse field with multiple career pathways and degree options to consider. For students seeking to enter allied health professions, exploring medical billing and coding financial aid opportunities can make education more accessible—and open doors to essential administrative roles in healthcare settings.

Nursing remains a highly sought-after profession for those passionate about patient care. Some absn programs that don't require teas exams offer accelerated transitions into nursing, helping students save time and reduce exam-related stress.

For those interested in leadership, management, or healthcare policy, there are accelerated healthcare programs available entirely online. These programs allow graduates to move quickly into high-impact positions across hospitals, clinics, and healthcare organizations.

Nurses aiming for advanced practice can also benefit from flexible educational options, such as asn to np programs. These bridge programs streamline the journey from nursing diploma or associate degrees to master’s-level qualifications, opening up broader clinical roles like Nurse Practitioner.

Best Scientists Citing Harry J.G.M. Crijns

Trending Scientists

Recently Published Articles